【资料图】

招商证券(香港)2月7日发布公告。We maintain BUY and SOTP TP at HKD65, as we think the worst is inthe rear-view mirror (e.g. PD-1 sales weakness and sales forcerestructuring), and recent broad-based market sentiment relief shoulddrive a re-rateforleading biotech names.

关键词： 招商证券 发布公告